AlphaYouMS
Insider selling
Michael Schmertzler sold $1.3M of Ptc Therapeutics, Inc. (PTCT) stock
Michael Schmertzler, Dir of Ptc Therapeutics, Inc. (PTCT), sold 20,000 shares of PTCT stock worth $1.3M, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 2 days before it was made public.
PTCT has moved -3.4% since the trade date, from $67.59 to $65.26 (Sep 21, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 2 days
- Price since
- -3.4%
- Role
- Dir
- Source
- SEC Form 4
More PTCT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.